- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04301245
Profile of COPD Patients Refusing Educational Program in Pulmonary Rehabilitation and Impact on the Benefits
Pulmonary rehabilitation (PR) has proven its efficacy to improve dyspnea, health status, exercise tolerance and quality of life for patients with stable Chronic Obstructive Pulmonary Disease (COPD). Exercise training has previously been thoroughly studied but education has been less studied in PR. Furthermore, only few studies have investigated the added value of an educational program (EP) to exercise training on clinical and physical factors. Characterizing those patients who refuse EP is therefore a first step to better target them and potentially improve their adherence and outcome following PR.
The aim of this study was to determine the characteristics of the COPD patients referred to PR who refused EP compare to those who accepted and to identify the independent predictive factors of refusal. The investigators also sought to compare the change in clinical outcomes and number and length of hospitalization at six months following PR among those patients who accepted or not to participate in EP.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Bois-Guillaume, France
- ADIR Association
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Clinical diagnosis of COPD,
- >18 years old,
- Stable state of COPD.
Exclusion Criteria:
- Patients who have not been offered an educational program
- Patients who have already been offered an educational program during a pulmonary rehabilitation in the same center.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
ETEP group
Exercise Training and Educational Program (ETEP) group.
Patients who accepted the educational program in addition to the exercise training.
|
The educational program (EP) was offered during the initial session of the pulmonary rehabilitation. According to the french law, patients were free to participate or not. The EP consisted of an educational diagnosis, educational workshops and an individual final assessment. |
ET group
Exercise Training (ET) group.
Patients who refused the educational program and did only the exercise training.
|
The educational program (EP) was offered during the initial session of the pulmonary rehabilitation. According to the french law, patients were free to participate or not. The EP consisted of an educational diagnosis, educational workshops and an individual final assessment. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Multiple logistic regression between the variables defined and the refusal of educational program
Time Frame: Baseline
|
The variables are described below in primary outcomes
|
Baseline
|
Gender
Time Frame: Baseline
|
Gender will be analysed in logistic regression.
|
Baseline
|
Age
Time Frame: Baseline
|
Age will be analysed in logistic regression.
|
Baseline
|
Height
Time Frame: Baseline
|
Height will be analysed in logistic regression.
|
Baseline
|
Weight
Time Frame: Baseline
|
Weight will be analysed in logistic regression.
|
Baseline
|
Body mass index
Time Frame: Baseline
|
Body mass index will be analysed in logistic regression.
|
Baseline
|
COPD stages
Time Frame: Baseline
|
COPD stages will be analysed in logistic regression.
|
Baseline
|
Forced Expiratory Volume in one second
Time Frame: Baseline
|
Forced Expiratory Volume in one second will be analysed in logistic regression.
|
Baseline
|
Forced Vital Capacity
Time Frame: Baseline
|
Forced Vital Capacity will be analysed in logistic regression.
|
Baseline
|
Ratio between Forced Expiratory Volume in one second and Forced Vital Capacity
Time Frame: Baseline
|
Ratio between Forced Expiratory Volume in one second and Forced Vital Capacity will be analysed in logistic regression.
|
Baseline
|
Total Lung Capacity
Time Frame: Baseline
|
Total Lung Capacity will be analysed in logistic regression.
|
Baseline
|
Residual Volume
Time Frame: Baseline
|
Residual Volume will be analysed in logistic regression.
|
Baseline
|
Diffusing capacity of the lungs for carbon monoxide divided by alveolar volume
Time Frame: Baseline
|
Diffusing capacity of the lungs for carbon monoxide divided by alveolar volume will be analysed in logistic regression.
|
Baseline
|
Comorbidities
Time Frame: Baseline
|
Comorbidities will be analysed in logistic regression.
|
Baseline
|
Tabacco status
Time Frame: Baseline
|
Tabacco status will be analysed in logistic regression.
|
Baseline
|
Tabacco consumption
Time Frame: Baseline
|
Tabacco consumption will be analysed in logistic regression.
|
Baseline
|
Prescription of oxygen
Time Frame: Baseline
|
Prescription of oxygen will be analysed in logistic regression.
|
Baseline
|
Prescription of non invasive ventilation
Time Frame: Baseline
|
Prescription of non invasive ventilation will be analysed in logistic regression.
|
Baseline
|
Arterial oxygen partial pressure
Time Frame: Baseline
|
Arterial oxygen partial pressure will be analysed in logistic regression.
|
Baseline
|
Arterial carbon dioxide partial pressure
Time Frame: Baseline
|
Arterial carbone dioxide partial pressure will be analysed in logistic regression.
|
Baseline
|
Location of the training sessions
Time Frame: Baseline
|
Location of the training sessions will be analysed in logistic regression.
|
Baseline
|
Ambulance transport
Time Frame: Baseline
|
Number of patients with an ambulance transport will be analysed in logistic regression.
|
Baseline
|
Distance between patient's home and center
Time Frame: Baseline
|
Distance between patient's home and center will be analysed in logistic regression.
|
Baseline
|
Dyspnea
Time Frame: Baseline
|
Dyspnea assessed by the modified Medical Research Council scale will be analysed in logistic regression.
|
Baseline
|
6-Minute Stepper Test
Time Frame: Baseline
|
Number of steps during the 6-Minute Stepper Test will be analysed in logistic regression.
|
Baseline
|
6-Minute Walk Test
Time Frame: Baseline
|
Distance during the 6-Minute Walk Test will be analysed in logistic regression.
|
Baseline
|
Maximal oxygen consumption
Time Frame: Baseline
|
Maximal oxygen consumption during cardiopulmonary exercise testing will be analysed in logistic regression.
|
Baseline
|
Maximal workload
Time Frame: Baseline
|
Maximal workload achieved during cardiopulmonary exercise testing will be analysed in logistic regression.
|
Baseline
|
Saint George's Respiratory Questionnaire
Time Frame: Baseline
|
Quality of life assessed by Saint George's Respiratory Questionnaire will be analysed in logistic regression.
|
Baseline
|
Employment
Time Frame: Baseline
|
Employment will be analysed in logistic regression.
|
Baseline
|
Educational level
Time Frame: Baseline
|
Educational level assessed by the international classification "Classification Internationale Type de l'Education" will be analysed in logistic regression.
|
Baseline
|
Cognitive impairment
Time Frame: Baseline
|
Cognitive impairment assessed by the Montreal Cognitive Assessment will be analysed in logistic regression.
|
Baseline
|
Anxiety and depression level
Time Frame: Baseline
|
Anxiety and depression level assessed by the Hospital Anxiety and Depression scale will be analysed in logistic regression.
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
6-Minute Stepper Test
Time Frame: 2 months
|
Change in number of steps during the 6-Minute Stepper Test will be compared between groups.
|
2 months
|
6-Minute Walk Test
Time Frame: 2 months
|
Change in distance during the 6-Minute Walk Test will be compared between groups.
|
2 months
|
Saint George's Respiratory Questionnaire
Time Frame: 2 months
|
Change in Saint George's Respiratory Questionnaire will be compared between groups.
|
2 months
|
Anxiety and depression level
Time Frame: 2 months
|
Anxiety and depression level assessed by the Hospital Anxiety and Depression scale will be analysed in logistic regression.
|
2 months
|
Cognitive impairment
Time Frame: 2 months
|
Change in cognitive impairment assessed by the Montreal Cognitive Assessment will be compared between groups.
|
2 months
|
Number of hospitalizations
Time Frame: 6 months
|
Number of hospitalizations will be compared between groups.
|
6 months
|
Number of hospitalized patients
Time Frame: 6 months
|
Number of hospitalized patients will be compared between groups.
|
6 months
|
Number of days of hospitalization
Time Frame: 6 months
|
Number of days of hospitalization will be compared between groups.
|
6 months
|
Attendance rate at educational sessions
Time Frame: 2 months
|
Attendance rate at education sessions will be analysed
|
2 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jean-François Muir, MD PhD, ADIR Association, Rouen University Hospital, Rouen, France;Normandie University, UNIROUEN, UPRES EA 3830, Rouen University Hospital, Haute-Normandie Research and Biomedical Innovation, Rouen, France
- Study Chair: Antoine Cuvelier, MD PhD, Normandie University, Rouen University Hospital, Haute-Normandie Research and Biomedical Innovation, Rouen, France ; Pulmonary, Thoracic Oncology and Respiratory Intensive Care Department, Rouen University Hospital, Rouen, France.
- Study Chair: David Debeaumont, MD, Department of Respiratory and Exercise Physiology and CICCRB 1404, Rouen University Hospital, Rouen France.
- Study Chair: Tristan Bonnevie, PT MSc, ADIR Association, Rouen University Hospital, Rouen, France ; Normandie University, UNIROUEN, UPRES EA 3830, Rouen University Hospital, Haute- Normandie Research and Biomedical Innovation, Rouen, France.
- Study Chair: Francis-Edouard Gravier, PT MSc, ADIR Association, Rouen University Hospital, Rouen, France ; Normandie University, UNIROUEN, UPRES EA 3830, Rouen University Hospital, Haute- Normandie Research and Biomedical Innovation, Rouen, France
- Study Chair: Pauline Smondack, PT, ADIR Association, Rouen University Hospital, Rouen, France.
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RETRO-ETP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Kırıkkale UniversityRecruitingCOPD (Chronic Obstructive Pulmonary Disease)Turkey
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on Educational program
-
Norwegian University of Science and TechnologyCompletedFecal Incontinence | Staffs' AttitudesNorway
-
Universidade Nova de LisboaCompletedAnxiety | Prescription Drug Abuse and DependencyPortugal
-
Medical University of GrazCompleted
-
Universitaire Ziekenhuizen KU LeuvenFund for Scientific Research, Flanders, BelgiumCompletedPain | Breast NeoplasmBelgium
-
University of BarcelonaFundació La Marató de TV3; SHE Foundation; Centro Nacional de Investigaciones... and other collaboratorsActive, not recruitingObesity | Diabetes Mellitus | Cardiovascular HealthSpain
-
The University of Texas Health Science Center at...National Heart, Lung, and Blood Institute (NHLBI)Completed
-
Cairo UniversityUnknown
-
National Center for Research Resources (NCRR)Virginia Commonwealth UniversityCompletedSystemic Lupus Erythematosus
-
Clinica Alemana de SantiagoNot yet recruiting
-
Assiut UniversityRecruiting